APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Banking and Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood Banking and Blood Products Market Analysis and Forecast 2026-2032

27 December 2025219 pages

Choose your research edition.

Industry ResearchBlood Banking and Blood Products Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Banking and Blood Products Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Banking and Blood Products Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Blood Banking and Blood Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Blood Banking and Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood Banking and Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood Banking and Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood Banking and Blood Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Blood Banking and Blood Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood Banking and Blood Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Banking and Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Banking and Blood Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Banking and Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Blood Banking and Blood Products revenue, projected growth trends, production technology, application and end-user industry.

Blood Banking and Blood Products Segment by Company

Red Cross Society of China

Yuanda Shuyang

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Vitalant

Takeda

Sanquin Blood Supply Foundation

Octapharma

NHS Blood and Transplant

New York Blood Center

National Blood Transfusion Council

LFB Group

KM Biologics

Kedrion

Japan Red Cross Society

Grifols

CSL

Canadian Blood Services

BPL

Blood Bank of Alaska

Biotest

Australia Red Cross

American Red Cross

America’s Blood Centers

Blood Banking and Blood Products Segment by Type

RBCs

Whole Blood

Plasma

Plasma Fractionation Products

Plts

Blood Banking and Blood Products Segment by Application

Clinic

Hospital

Retail Pharmacy

Others

Blood Banking and Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Blood Banking and Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Blood Banking and Blood Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Banking and Blood Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Banking and Blood Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RBCs Major Player Table 3. Whole Blood Major Player Table 4. Plasma Major Player Table 5. Plasma Fractionation Products Major Player Table 6. Plts Major Player Table 7. Global Blood Banking and Blood Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Player Table 9. Hospital Major Player Table 10. Retail Pharmacy Major Player Table 11. Others Major Player Table 12. Blood Banking and Blood Products Industry Trends Table 13. Blood Banking and Blood Products Industry Drivers Table 14. Blood Banking and Blood Products Industry Opportunities and Challenges Table 15. Blood Banking and Blood Products Industry Restraints Table 16. Global Blood Banking and Blood Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Blood Banking and Blood Products Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Blood Banking and Blood Products Market Share by Region (2021-2026) Table 19. Global Blood Banking and Blood Products Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Blood Banking and Blood Products Market Share by Region (2027-2032) Table 21. Global Blood Banking and Blood Products Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Blood Banking and Blood Products Revenue Market Share by Players (2021-2026) Table 23. Global Blood Banking and Blood Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Blood Banking and Blood Products Key Players Headquarters & Area Served Table 25. Global Blood Banking and Blood Products Players, Product Type & Application Table 26. Global Blood Banking and Blood Products Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Blood Banking and Blood Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Blood Banking and Blood Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2026) Table 33. Global Blood Banking and Blood Products Revenue Market Share by Type (2027-2032) Table 34. Global Blood Banking and Blood Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2026) Table 38. Global Blood Banking and Blood Products Revenue Market Share by Application (2027-2032) Table 39. Red Cross Society of China Company Information Table 40. Red Cross Society of China Business Overview Table 41. Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Red Cross Society of China Blood Banking and Blood Products Product Portfolio Table 43. Red Cross Society of China Recent Development Table 44. Yuanda Shuyang Company Information Table 45. Yuanda Shuyang Business Overview Table 46. Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Yuanda Shuyang Blood Banking and Blood Products Product Portfolio Table 48. Yuanda Shuyang Recent Development Table 49. Weiguang Bio Company Information Table 50. Weiguang Bio Business Overview Table 51. Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Weiguang Bio Blood Banking and Blood Products Product Portfolio Table 53. Weiguang Bio Recent Development Table 54. Tiantan Bio Company Information Table 55. Tiantan Bio Business Overview Table 56. Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Tiantan Bio Blood Banking and Blood Products Product Portfolio Table 58. Tiantan Bio Recent Development Table 59. CBPO Company Information Table 60. CBPO Business Overview Table 61. CBPO Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. CBPO Blood Banking and Blood Products Product Portfolio Table 63. CBPO Recent Development Table 64. Shuanglin Bio Company Information Table 65. Shuanglin Bio Business Overview Table 66. Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Shuanglin Bio Blood Banking and Blood Products Product Portfolio Table 68. Shuanglin Bio Recent Development Table 69. RAAS Company Information Table 70. RAAS Business Overview Table 71. RAAS Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. RAAS Blood Banking and Blood Products Product Portfolio Table 73. RAAS Recent Development Table 74. Nanyue Bio Company Information Table 75. Nanyue Bio Business Overview Table 76. Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Nanyue Bio Blood Banking and Blood Products Product Portfolio Table 78. Nanyue Bio Recent Development Table 79. Hualan Bio Company Information Table 80. Hualan Bio Business Overview Table 81. Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Hualan Bio Blood Banking and Blood Products Product Portfolio Table 83. Hualan Bio Recent Development Table 84. Boya Bio Company Information Table 85. Boya Bio Business Overview Table 86. Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Boya Bio Blood Banking and Blood Products Product Portfolio Table 88. Boya Bio Recent Development Table 89. Vitalant Company Information Table 90. Vitalant Business Overview Table 91. Vitalant Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Vitalant Blood Banking and Blood Products Product Portfolio Table 93. Vitalant Recent Development Table 94. Takeda Company Information Table 95. Takeda Business Overview Table 96. Takeda Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Takeda Blood Banking and Blood Products Product Portfolio Table 98. Takeda Recent Development Table 99. Sanquin Blood Supply Foundation Company Information Table 100. Sanquin Blood Supply Foundation Business Overview Table 101. Sanquin Blood Supply Foundation Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio Table 103. Sanquin Blood Supply Foundation Recent Development Table 104. Octapharma Company Information Table 105. Octapharma Business Overview Table 106. Octapharma Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Octapharma Blood Banking and Blood Products Product Portfolio Table 108. Octapharma Recent Development Table 109. NHS Blood and Transplant Company Information Table 110. NHS Blood and Transplant Business Overview Table 111. NHS Blood and Transplant Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio Table 113. NHS Blood and Transplant Recent Development Table 114. New York Blood Center Company Information Table 115. New York Blood Center Business Overview Table 116. New York Blood Center Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. New York Blood Center Blood Banking and Blood Products Product Portfolio Table 118. New York Blood Center Recent Development Table 119. National Blood Transfusion Council Company Information Table 120. National Blood Transfusion Council Business Overview Table 121. National Blood Transfusion Council Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio Table 123. National Blood Transfusion Council Recent Development Table 124. LFB Group Company Information Table 125. LFB Group Business Overview Table 126. LFB Group Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. LFB Group Blood Banking and Blood Products Product Portfolio Table 128. LFB Group Recent Development Table 129. KM Biologics Company Information Table 130. KM Biologics Business Overview Table 131. KM Biologics Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. KM Biologics Blood Banking and Blood Products Product Portfolio Table 133. KM Biologics Recent Development Table 134. Kedrion Company Information Table 135. Kedrion Business Overview Table 136. Kedrion Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Kedrion Blood Banking and Blood Products Product Portfolio Table 138. Kedrion Recent Development Table 139. Japan Red Cross Society Company Information Table 140. Japan Red Cross Society Business Overview Table 141. Japan Red Cross Society Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Japan Red Cross Society Blood Banking and Blood Products Product Portfolio Table 143. Japan Red Cross Society Recent Development Table 144. Grifols Company Information Table 145. Grifols Business Overview Table 146. Grifols Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Grifols Blood Banking and Blood Products Product Portfolio Table 148. Grifols Recent Development Table 149. CSL Company Information Table 150. CSL Business Overview Table 151. CSL Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. CSL Blood Banking and Blood Products Product Portfolio Table 153. CSL Recent Development Table 154. Canadian Blood Services Company Information Table 155. Canadian Blood Services Business Overview Table 156. Canadian Blood Services Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Canadian Blood Services Blood Banking and Blood Products Product Portfolio Table 158. Canadian Blood Services Recent Development Table 159. BPL Company Information Table 160. BPL Business Overview Table 161. BPL Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. BPL Blood Banking and Blood Products Product Portfolio Table 163. BPL Recent Development Table 164. Blood Bank of Alaska Company Information Table 165. Blood Bank of Alaska Business Overview Table 166. Blood Bank of Alaska Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio Table 168. Blood Bank of Alaska Recent Development Table 169. Biotest Company Information Table 170. Biotest Business Overview Table 171. Biotest Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Biotest Blood Banking and Blood Products Product Portfolio Table 173. Biotest Recent Development Table 174. Australia Red Cross Company Information Table 175. Australia Red Cross Business Overview Table 176. Australia Red Cross Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Australia Red Cross Blood Banking and Blood Products Product Portfolio Table 178. Australia Red Cross Recent Development Table 179. American Red Cross Company Information Table 180. American Red Cross Business Overview Table 181. American Red Cross Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. American Red Cross Blood Banking and Blood Products Product Portfolio Table 183. American Red Cross Recent Development Table 184. America’s Blood Centers Company Information Table 185. America’s Blood Centers Business Overview Table 186. America’s Blood Centers Blood Banking and Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. America’s Blood Centers Blood Banking and Blood Products Product Portfolio Table 188. America’s Blood Centers Recent Development Table 189. North America Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 190. North America Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 191. North America Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 192. North America Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 193. North America Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. North America Blood Banking and Blood Products Revenue by Country (2021-2026) & (US$ Million) Table 195. North America Blood Banking and Blood Products Revenue by Country (US$ Million) & (2027-2032) Table 196. Europe Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 197. Europe Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 198. Europe Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 199. Europe Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 200. Europe Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Europe Blood Banking and Blood Products Revenue by Country (2021-2026) & (US$ Million) Table 202. Europe Blood Banking and Blood Products Revenue by Country (US$ Million) & (2027-2032) Table 203. China Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 204. China Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 205. China Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 206. China Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 207. Asia Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Blood Banking and Blood Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Asia Blood Banking and Blood Products Revenue by Region (US$ Million) & (2021-2026) Table 213. Asia Blood Banking and Blood Products Revenue by Region (US$ Million) & (2027-2032) Table 214. SAMEA Blood Banking and Blood Products Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Blood Banking and Blood Products Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Blood Banking and Blood Products Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA Blood Banking and Blood Products Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Blood Banking and Blood Products Revenue by Country (2021-2026) & (US$ Million) Table 220. SAMEA Blood Banking and Blood Products Revenue by Country (US$ Million) & (2027-2032) Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Blood Banking and Blood Products Image Figure 2. Global Blood Banking and Blood Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Banking and Blood Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. RBCs Image Figure 5. Whole Blood Image Figure 6. Plasma Image Figure 7. Plasma Fractionation Products Image Figure 8. Plts Image Figure 9. Global Blood Banking and Blood Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Blood Banking and Blood Products Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Retail Pharmacy Image Figure 14. Others Image Figure 15. Global Blood Banking and Blood Products Market Size (US$ Million) & (2021-2032) Figure 16. Global Blood Banking and Blood Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Blood Banking and Blood Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Blood Banking and Blood Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Blood Banking and Blood Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Blood Banking and Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2032) Figure 23. Global Blood Banking and Blood Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Blood Banking and Blood Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2032) Figure 26. North America Blood Banking and Blood Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Blood Banking and Blood Products Revenue Share by Type (2021-2032) Figure 28. North America Blood Banking and Blood Products Revenue Share by Application (2021-2032) Figure 29. North America Blood Banking and Blood Products Revenue Share by Country (2021-2032) Figure 30. United States Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Blood Banking and Blood Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Blood Banking and Blood Products Revenue Share by Type (2021-2032) Figure 35. Europe Blood Banking and Blood Products Revenue Share by Application (2021-2032) Figure 36. Europe Blood Banking and Blood Products Revenue Share by Country (2021-2032) Figure 37. Germany Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Blood Banking and Blood Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Blood Banking and Blood Products Revenue Share by Type (2021-2032) Figure 47. China Blood Banking and Blood Products Revenue Share by Application (2021-2032) Figure 48. Asia Blood Banking and Blood Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Blood Banking and Blood Products Revenue Share by Type (2021-2032) Figure 50. Asia Blood Banking and Blood Products Revenue Share by Application (2021-2032) Figure 51. Asia Blood Banking and Blood Products Revenue Share by Region (2021-2032) Figure 52. Japan Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Blood Banking and Blood Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Blood Banking and Blood Products Revenue Share by Type (2021-2032) Figure 60. SAMEA Blood Banking and Blood Products Revenue Share by Application (2021-2032) Figure 61. SAMEA Blood Banking and Blood Products Revenue Share by Country (2021-2032) Figure 62. Brazil Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Blood Banking and Blood Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • RBCs
  • Whole Blood
  • Plasma
  • Plasma Fractionation Products
  • Plts
Applications
  • Clinic
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Red Cross Society of China
  • Yuanda Shuyang
  • Weiguang Bio
  • Tiantan Bio
  • CBPO
  • Shuanglin Bio
  • RAAS
  • Nanyue Bio
  • Hualan Bio
  • Boya Bio
  • Vitalant
  • Takeda
  • Sanquin Blood Supply Foundation
  • Octapharma
  • NHS Blood and Transplant
  • New York Blood Center
  • National Blood Transfusion Council
  • LFB Group
  • KM Biologics
  • Kedrion
  • Japan Red Cross Society
  • Grifols
  • CSL
  • Canadian Blood Services
  • BPL
  • Blood Bank of Alaska
  • Biotest
  • Australia Red Cross
  • American Red Cross
  • America’s Blood Centers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood Banking and Blood Products Market by Type
  3. 1.2.1 Global Blood Banking and Blood Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RBCs
  5. 1.2.3 Whole Blood
  6. 1.2.4 Plasma
  7. 1.2.5 Plasma Fractionation Products
  8. 1.2.6 Plts
  9. 1.3 Blood Banking and Blood Products Market by Application
  10. 1.3.1 Global Blood Banking and Blood Products Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Retail Pharmacy
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Blood Banking and Blood Products Market Dynamics
  1. 2.1 Blood Banking and Blood Products Industry Trends
  2. 2.2 Blood Banking and Blood Products Industry Drivers
  3. 2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
  4. 2.4 Blood Banking and Blood Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Blood Banking and Blood Products Market Perspective (2021-2032)
  2. 3.2 Global Blood Banking and Blood Products Growth Trends by Region
  3. 3.2.1 Global Blood Banking and Blood Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood Banking and Blood Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Blood Banking and Blood Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Blood Banking and Blood Products Revenue by Players
  2. 4.1.1 Global Blood Banking and Blood Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Blood Banking and Blood Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Blood Banking and Blood Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood Banking and Blood Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Blood Banking and Blood Products Key Players Headquarters & Area Served
  7. 4.4 Global Blood Banking and Blood Products Players, Product Type & Application
  8. 4.5 Global Blood Banking and Blood Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Blood Banking and Blood Products Market CR5 and HHI
  11. 4.6.3 2025 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3
5 Blood Banking and Blood Products Market Size by Type
  1. 5.1 Global Blood Banking and Blood Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 5.3 Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2032)
6 Blood Banking and Blood Products Market Size by Application
  1. 6.1 Global Blood Banking and Blood Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Blood Banking and Blood Products Revenue by Application (2021-2032)
  3. 6.3 Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Red Cross Society of China
  2. 7.1.1 Red Cross Society of China Company Information
  3. 7.1.2 Red Cross Society of China Business Overview
  4. 7.1.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
  6. 7.1.5 Red Cross Society of China Recent Developments
  7. 7.2 Yuanda Shuyang
  8. 7.2.1 Yuanda Shuyang Company Information
  9. 7.2.2 Yuanda Shuyang Business Overview
  10. 7.2.3 Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
  12. 7.2.5 Yuanda Shuyang Recent Developments
  13. 7.3 Weiguang Bio
  14. 7.3.1 Weiguang Bio Company Information
  15. 7.3.2 Weiguang Bio Business Overview
  16. 7.3.3 Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
  18. 7.3.5 Weiguang Bio Recent Developments
  19. 7.4 Tiantan Bio
  20. 7.4.1 Tiantan Bio Company Information
  21. 7.4.2 Tiantan Bio Business Overview
  22. 7.4.3 Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
  24. 7.4.5 Tiantan Bio Recent Developments
  25. 7.5 CBPO
  26. 7.5.1 CBPO Company Information
  27. 7.5.2 CBPO Business Overview
  28. 7.5.3 CBPO Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CBPO Blood Banking and Blood Products Product Portfolio
  30. 7.5.5 CBPO Recent Developments
  31. 7.6 Shuanglin Bio
  32. 7.6.1 Shuanglin Bio Company Information
  33. 7.6.2 Shuanglin Bio Business Overview
  34. 7.6.3 Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
  36. 7.6.5 Shuanglin Bio Recent Developments
  37. 7.7 RAAS
  38. 7.7.1 RAAS Company Information
  39. 7.7.2 RAAS Business Overview
  40. 7.7.3 RAAS Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RAAS Blood Banking and Blood Products Product Portfolio
  42. 7.7.5 RAAS Recent Developments
  43. 7.8 Nanyue Bio
  44. 7.8.1 Nanyue Bio Company Information
  45. 7.8.2 Nanyue Bio Business Overview
  46. 7.8.3 Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
  48. 7.8.5 Nanyue Bio Recent Developments
  49. 7.9 Hualan Bio
  50. 7.9.1 Hualan Bio Company Information
  51. 7.9.2 Hualan Bio Business Overview
  52. 7.9.3 Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
  54. 7.9.5 Hualan Bio Recent Developments
  55. 7.10 Boya Bio
  56. 7.10.1 Boya Bio Company Information
  57. 7.10.2 Boya Bio Business Overview
  58. 7.10.3 Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
  60. 7.10.5 Boya Bio Recent Developments
  61. 7.11 Vitalant
  62. 7.11.1 Vitalant Company Information
  63. 7.11.2 Vitalant Business Overview
  64. 7.11.3 Vitalant Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
  66. 7.11.5 Vitalant Recent Developments
  67. 7.12 Takeda
  68. 7.12.1 Takeda Company Information
  69. 7.12.2 Takeda Business Overview
  70. 7.12.3 Takeda Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Takeda Blood Banking and Blood Products Product Portfolio
  72. 7.12.5 Takeda Recent Developments
  73. 7.13 Sanquin Blood Supply Foundation
  74. 7.13.1 Sanquin Blood Supply Foundation Company Information
  75. 7.13.2 Sanquin Blood Supply Foundation Business Overview
  76. 7.13.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
  78. 7.13.5 Sanquin Blood Supply Foundation Recent Developments
  79. 7.14 Octapharma
  80. 7.14.1 Octapharma Company Information
  81. 7.14.2 Octapharma Business Overview
  82. 7.14.3 Octapharma Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
  84. 7.14.5 Octapharma Recent Developments
  85. 7.15 NHS Blood and Transplant
  86. 7.15.1 NHS Blood and Transplant Company Information
  87. 7.15.2 NHS Blood and Transplant Business Overview
  88. 7.15.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  89. 7.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
  90. 7.15.5 NHS Blood and Transplant Recent Developments
  91. 7.16 New York Blood Center
  92. 7.16.1 New York Blood Center Company Information
  93. 7.16.2 New York Blood Center Business Overview
  94. 7.16.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  95. 7.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
  96. 7.16.5 New York Blood Center Recent Developments
  97. 7.17 National Blood Transfusion Council
  98. 7.17.1 National Blood Transfusion Council Company Information
  99. 7.17.2 National Blood Transfusion Council Business Overview
  100. 7.17.3 National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  101. 7.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
  102. 7.17.5 National Blood Transfusion Council Recent Developments
  103. 7.18 LFB Group
  104. 7.18.1 LFB Group Company Information
  105. 7.18.2 LFB Group Business Overview
  106. 7.18.3 LFB Group Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  107. 7.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
  108. 7.18.5 LFB Group Recent Developments
  109. 7.19 KM Biologics
  110. 7.19.1 KM Biologics Company Information
  111. 7.19.2 KM Biologics Business Overview
  112. 7.19.3 KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  113. 7.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
  114. 7.19.5 KM Biologics Recent Developments
  115. 7.20 Kedrion
  116. 7.20.1 Kedrion Company Information
  117. 7.20.2 Kedrion Business Overview
  118. 7.20.3 Kedrion Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
  120. 7.20.5 Kedrion Recent Developments
  121. 7.21 Japan Red Cross Society
  122. 7.21.1 Japan Red Cross Society Company Information
  123. 7.21.2 Japan Red Cross Society Business Overview
  124. 7.21.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
  126. 7.21.5 Japan Red Cross Society Recent Developments
  127. 7.22 Grifols
  128. 7.22.1 Grifols Company Information
  129. 7.22.2 Grifols Business Overview
  130. 7.22.3 Grifols Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Grifols Blood Banking and Blood Products Product Portfolio
  132. 7.22.5 Grifols Recent Developments
  133. 7.23 CSL
  134. 7.23.1 CSL Company Information
  135. 7.23.2 CSL Business Overview
  136. 7.23.3 CSL Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  137. 7.23.4 CSL Blood Banking and Blood Products Product Portfolio
  138. 7.23.5 CSL Recent Developments
  139. 7.24 Canadian Blood Services
  140. 7.24.1 Canadian Blood Services Company Information
  141. 7.24.2 Canadian Blood Services Business Overview
  142. 7.24.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
  144. 7.24.5 Canadian Blood Services Recent Developments
  145. 7.25 BPL
  146. 7.25.1 BPL Company Information
  147. 7.25.2 BPL Business Overview
  148. 7.25.3 BPL Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  149. 7.25.4 BPL Blood Banking and Blood Products Product Portfolio
  150. 7.25.5 BPL Recent Developments
  151. 7.26 Blood Bank of Alaska
  152. 7.26.1 Blood Bank of Alaska Company Information
  153. 7.26.2 Blood Bank of Alaska Business Overview
  154. 7.26.3 Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
  156. 7.26.5 Blood Bank of Alaska Recent Developments
  157. 7.27 Biotest
  158. 7.27.1 Biotest Company Information
  159. 7.27.2 Biotest Business Overview
  160. 7.27.3 Biotest Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Biotest Blood Banking and Blood Products Product Portfolio
  162. 7.27.5 Biotest Recent Developments
  163. 7.28 Australia Red Cross
  164. 7.28.1 Australia Red Cross Company Information
  165. 7.28.2 Australia Red Cross Business Overview
  166. 7.28.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
  168. 7.28.5 Australia Red Cross Recent Developments
  169. 7.29 American Red Cross
  170. 7.29.1 American Red Cross Company Information
  171. 7.29.2 American Red Cross Business Overview
  172. 7.29.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  173. 7.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
  174. 7.29.5 American Red Cross Recent Developments
  175. 7.30 America’s Blood Centers
  176. 7.30.1 America’s Blood Centers Company Information
  177. 7.30.2 America’s Blood Centers Business Overview
  178. 7.30.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  179. 7.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
  180. 7.30.5 America’s Blood Centers Recent Developments
8 North America
  1. 8.1 North America Blood Banking and Blood Products Revenue (2021-2032)
  2. 8.2 North America Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Blood Banking and Blood Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Blood Banking and Blood Products Revenue by Type (2027-2032)
  5. 8.3 North America Blood Banking and Blood Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Blood Banking and Blood Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Blood Banking and Blood Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Blood Banking and Blood Products Revenue by Application (2027-2032)
  9. 8.5 North America Blood Banking and Blood Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Blood Banking and Blood Products Revenue by Country
  11. 8.6.1 North America Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Blood Banking and Blood Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Blood Banking and Blood Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Blood Banking and Blood Products Revenue (2021-2032)
  2. 9.2 Europe Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Blood Banking and Blood Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Blood Banking and Blood Products Revenue by Type (2027-2032)
  5. 9.3 Europe Blood Banking and Blood Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Blood Banking and Blood Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Blood Banking and Blood Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Blood Banking and Blood Products Revenue by Application (2027-2032)
  9. 9.5 Europe Blood Banking and Blood Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Blood Banking and Blood Products Revenue by Country
  11. 9.6.1 Europe Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Blood Banking and Blood Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Blood Banking and Blood Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Blood Banking and Blood Products Revenue (2021-2032)
  2. 10.2 China Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 10.2.1 China Blood Banking and Blood Products Revenue by Type (2021-2026)
  4. 10.2.2 China Blood Banking and Blood Products Revenue by Type (2027-2032)
  5. 10.3 China Blood Banking and Blood Products Revenue Share by Type (2021-2032)
  6. 10.4 China Blood Banking and Blood Products Revenue by Application (2021-2032)
  7. 10.4.1 China Blood Banking and Blood Products Revenue by Application (2021-2026)
  8. 10.4.2 China Blood Banking and Blood Products Revenue by Application (2027-2032)
  9. 10.5 China Blood Banking and Blood Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood Banking and Blood Products Revenue (2021-2032)
  2. 11.2 Asia Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Blood Banking and Blood Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Blood Banking and Blood Products Revenue by Type (2027-2032)
  5. 11.3 Asia Blood Banking and Blood Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Blood Banking and Blood Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Blood Banking and Blood Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Blood Banking and Blood Products Revenue by Application (2027-2032)
  9. 11.5 Asia Blood Banking and Blood Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Blood Banking and Blood Products Revenue by Country
  11. 11.6.1 Asia Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Blood Banking and Blood Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Blood Banking and Blood Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood Banking and Blood Products Revenue (2021-2032)
  2. 12.2 SAMEA Blood Banking and Blood Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Blood Banking and Blood Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Blood Banking and Blood Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Blood Banking and Blood Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Blood Banking and Blood Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Blood Banking and Blood Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Blood Banking and Blood Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Blood Banking and Blood Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Blood Banking and Blood Products Revenue by Country
  11. 12.6.1 SAMEA Blood Banking and Blood Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Blood Banking and Blood Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Blood Banking and Blood Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst